Drugs Made In America Acquisition II Corp. (DMIIR)New York, United States | NasdaqGM
0.07 USD
+0.01
(7.858%)
⇧
(Oct. 9, 2026, 4 p.m.
EDT)
|
Hot Take ↕ | Oct. 10, 2026, 10:09 a.m. EDT
The security is a distressed shell company trading at a fraction of its book value due to massive liabilities and negative operating cash flow, making it a speculative gamble rather than an investment. With no price history to establish a trend, no dividend to provide income, and a balance sheet showing debt significantly outweighing cash, the risk of permanent capital loss is extreme. The lack of analyst coverage and the 'no model' status for forecasting further confirm that there is no discernible path to recovery or appreciation in the near term. |
| Attribute | Value |
|---|---|
| Address1 | 420 Lexington Avenue |
| Address2 | Suite 1402 |
| Ask | 0.1 |
| Ask Size | 5 |
| Bid | 0.0651 |
| Bid Size | 1 |
| Book Value | -0.281 |
| City | New York |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.07 |
| Current Ratio | 0.338 |
| Custom Price Alert Confidence | HIGH |
| Day High | 0.07 |
| Day Low | 0.053 |
| Display Name | Drugs Made In America Acq II |
| Ebitda Margins | 0.0 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 15 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Two Week High | 0.07 |
| Fifty Two Week High Change | 0.0 |
| Fifty Two Week High Change Percent | 0.0 |
| Fifty Two Week Low | 0.053 |
| Fifty Two Week Low Change | 0.017 |
| Fifty Two Week Low Change Percent | 0.32075474 |
| Fifty Two Week Range | 0.053 - 0.07 |
| Financial Currency | USD |
| Float Shares | 54,008,045 |
| Full Exchange Name | NasdaqGM |
| Fullday Change | 0.005099997 |
| Fullday Change Percent | 10.647175 |
| Fullday Price | 0.07 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Industry | |
| Industry Key | |
| Ipo Expected Date | 2,025-12-03 |
| Language | en-US |
| Long Business Summary | Drugs Made In America Acquisition II Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. It intends to source and evaluate companies focused on the pharmaceutical sector. Drugs Made In America Acquisition II Corp. was incorporated in 2024 and is based in New York, New York. |
| Long Name | Drugs Made In America Acquisition II Corp. |
| Market | us_market |
| Market State | PRE |
| Max Age | 86,400 |
| Message Board Id | finmb_1938104325 |
| Net Income To Common | 13,018,726 |
| Open | 0.053 |
| Operating Cashflow | -1,280,839 |
| Operating Margins | 0.0 |
| Phone | 917 982 4565 |
| Previous Close | 0.0649 |
| Price Hint | 4 |
| Price To Book | -0.24911033 |
| Profit Margins | 0.0 |
| Quick Ratio | 0.271 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.005099997 |
| Regular Market Change Percent | 7.858238 |
| Regular Market Day High | 0.07 |
| Regular Market Day Low | 0.053 |
| Regular Market Day Range | 0.053 - 0.07 |
| Regular Market Open | 0.053 |
| Regular Market Previous Close | 0.0649 |
| Regular Market Price | 0.07 |
| Regular Market Time | 1,791,576,000 |
| Regular Market Volume | 1,763 |
| Sand P52 Week Change | 0.17383456 |
| Sector | |
| Sector Key | |
| Short Name | Drugs Made In America Acquisiti |
| Source Interval | 15 |
| State | NY |
| Symbol | DMIIR |
| Total Cash | 174,974 |
| Total Cash Per Share | 0.003 |
| Total Debt | 450,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Type Disp | Equity |
| Volume | 1,763 |
| Zip | 10,170 |